CDC official: Several hundred polio cases likely circulating in New York
An official from the Centers for Disease Control and Prevention (CDC) said Thursday that a polio case detected in New York last month, the first […]
An official from the Centers for Disease Control and Prevention (CDC) said Thursday that a polio case detected in New York last month, the first […]
Pfizer’s own R&D efforts in sickle cell disease have fallen short, so the pharmaceutical giant is turning to M&A to gain a presence in the […]
KHN senior correspondent Arthur Allen discussed New York’s polio case with WBEZ’s “Reset With Sasha-Ann Simons” on Aug. 2. Click here to hear Allen on […]
KHN Midwest correspondent Lauren Weber appeared on CBS News’ streaming network to discuss “Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped,” an article she […]
Las clínicas que tratan las enfermedades de transmisión sexual —que ya se enfrentaban a un aumento explosivo de enfermedades como la sífilis y la gonorrea— […]
Regeneron Pharmaceuticals has big plans for cancer immunotherapy Libtayo and it believes it can better execute on them if it has full control of the […]
When consumer healthcare products joint venture Haleon spins out from GSK as an independent company next month, Pfizer will sell its minority stake in the […]
Life sciences companies are increasingly committing themselves to Net Zero goals, laying out plans for reaching zero emissions by 2050 or earlier. This is a […]
After his company acquired Daraprim, it raised price of the life-saving drug by 5,000%, prompting national outcry Martin Shkreli, the “Pharma Bro” entrepreneur who astronomically […]
The New York City Department of Health and Mental Hygiene is now advising residents to wear masks when indoors, citing the rise in community infections […]
New York Gov. Kathy Hochul (D) announced on Tuesday that the state is allocating $35 million to support abortion providers after a leaked Supreme Court […]
Bristol Myers Squibb drug Camzyos has FDA approval for treating obstructive hypertrophic cardiomyopathy, a rare and potentially fatal heart disorder. The drug is projected to […]
Regeneron Pharmaceuticals is paying $250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. The biotech’s lead […]
While COVID-19 cases have remained low in the U.S. since the decline of the omicron wave this winter, the “stealth” BA.2 variant has reached the […]
The rate of new COVID-19 cases is at the lowest it’s been since last summer as the omicron wave subsides. As state governments have begun […]
Wylie James Prescott, de 3 años, tuvo que esperar más de un año después de su diagnóstico de autismo para comenzar la terapia conductual, a […]
Bristol Myers Squibb’s Opdualag has been approved by the FDA, a first for a drug that goes after a new cancer target called LAG-3. The […]
Sanofi and digital therapeutics company DarioHealth will work together to promote the tech firm’s offerings for the management of chronic diseases. Under the $30 million, […]
Jenni Mahnaz admite que no le gustan mucho los perros. Es ligeramente alérgica y la única mascota que tuvo de niña fue un cangrejo ermitaño. […]
Jenni Mahnaz admits she’s not much of a dog person. She’s mildly allergic and the only pet she had as a child was a hermit […]
Sometimes even a clinical trial where the endpoints have been met may not give the […]
Topography Health announced their 27.5M series A funding for their clinical trials technology led by Andreessen Horowitz and Bain Capital Ventures.
Andrew Bott, Director of Talent Acquisition in EMEA & APAC countries at Medidata, shared his insights on hiring trends in this sector, in response to […]
The FDA has rejected Pfizer’s somatrogon, a long-acting form of human growth hormone designed for once-weekly dosing. The setback delays Pfizer and partner Opko Health […]
Eleusis is developing a formulation of the psychedelic compound psilocybin that overcomes limitations of pill versions of the drug. Depression is Eleusis’s lead disease target […]
A medida que los casos de covid-19 vuelven a aumentar en los hogares de adultos mayores, algunos estados han empezado a exigir a los visitantes […]
As covid-19 cases rise again in nursing homes, a few states have begun requiring visitors to present proof that they’re not infected before entering facilities, […]
NUEVA YORK, NY.- En los últimos meses, los sitios para pruebas de covid en carpas y camiones se han multiplicado en las calles como la […]
NEW YORK — In recent months, mobile covid-19 testing tents and vans have sprouted on urban sidewalks and street curbs as demand has skyrocketed in […]
Tammy Kaminski can still recall the taste of benzene, a carcinogenic byproduct of burning jet fuel. For nine months after the 9/11 attacks, she volunteered […]
BeyondSpring Pharmaceuticals’ corporate reorganization comes about six weeks after the FDA rejected the biotech’s drug for a complication experienced by cancer patients. The company still […]
Pfizer is paying BioNTech $225 million to kick off a new alliance aiming to develop a shingles vaccine based on the same messenger RNA technology […]
Health analytics firm Aetion has acquired Replica Analytics, a company that specializes in synthetic data. Aetion said Replica will enable it to analyze previously inaccessible […]
Ovid Therapeutics is acquiring global rights to AstraZeneca molecules that address a novel target to treat epilepsy. The AstraZeneca deal comes 10 months after Takeda […]
The FDA has halted tests of a Pfizer gene therapy for Duchenne muscular dystrophy. The clinical hold is one of several placed on gene therapy […]
Bristol Myers Squibb has notched another FDA approval for its blockbuster immunology drug Orencia, this time for preventing acute graft versus host disease in bone […]
New York’s Metropolitan Museum has cut public ties with the Purdue Pharma opioid-crisis family. But its name is now as thought-provoking as much of the […]
Bristol Myers Squibb is paying $150 million up front for global rights to an Immatics biologic drug designed to recruit a patient’s T cells to […]
Sales of blockbuster Pfizer drug Xeljanz are under pressure from a stronger safety warning placed across that drug’s entire class. In acquiring Arena Pharmaceuticals for […]
BeyondSpring Pharmaceuticals said the FDA wants another clinical trial to demonstrate patient benefit for its drug, a small molecule developed to treat a dangerous and […]
Talkspace’s COO Mark Hirschhorn is resigning after an internal review of his conduct, the company shared. This comes just a week after the departure of […]
The sum represents Sanofi’s equity investment in Owkin, plus a payment to begin a research partnership covering four types of cancer. Meanwhile, Owkin said the […]
The company, which pulls together information on clinicians and researchers, recently closed a funding round led by Altimeter Capital. It plans to use the funds […]
Valera Health provides teletherapy services for mental health, ranging from mild to serious conditions. The company recently raised $15 million in funding led by Windham […]
En estos días, los trabajadores que se niegan a vacunarse contra covid-19 pueden enfrentar repercusiones financieras, desde primas de planes médicos más altas hasta la […]
These days, workers who refuse to get vaccinated against covid-19 may face financial repercussions, from higher health insurance premiums to loss of their jobs. Now, […]
Nursing homes receive billions of taxpayers’ dollars every year to care for chronically ill frail elders, but until now, there was no guarantee that’s how […]
From her Baltimore dining room, Susan Goodlaxson can see her neighbor gardening across the street. But while other neighbors stop to chat, Goodlaxson just watches […]
Oshi Health raised $23 million in funding, with CVS Health and Takeda joining as strategic investors. The company has built a digital health platform to […]
Five New York state and local government agencies agreed to fix covid-19 vaccine websites to make them accessible for blind users following a Department of […]
Bristol Myers Squibb drug deucravacitinib missed the main and secondary goals of a Phase 2 study in ulcerative colitis. Despite the clinical trial failure, the […]
Empire members will gain access to three Mount Sinai Health System care models, which enable patients to opt for in-home care when medically appropriate. The […]
TrialSpark, a startup whose software manages various aspects of clinical trials, is becoming a drug developer. Led by CEO and cofounder Benjamine Liu, the company […]
After Capital Rx’s former medical director of pharmacy services got a job offer at CVS, the PBM startup claimed he couldn’t work there because of […]
Can’t see the audio player? Click here to listen. In 2004, 24-year-old Manny Lanza urgently needed surgery for a life-threatening brain condition. But he didn’t have […]
A lower-dose version of Pfizer and BioNTech’s Covid-19 vaccine showed safety and efficacy results in children 5 to 11 that were comparable to those in […]
The company, which offers mental health solutions for employers and health plans, recently closed a $190 million series C round, that included both equity and […]
Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, […]
Ray Pfeifer and Luis Alvarez’s names are on the federal 9/11 legislation that establishes benefits for first responders. Both men fought to make Congress pass […]
The cash deal brings to Sanofi the Kadmon Holdings drug Rezurock, which the FDA approved in July as a treatment for chronic graft versus host […]
The company rolled out a tool to help pharmaceutical companies pull together information about clinical trial sites and identify the best physician investigators for a […]
The startup, where patients access cash-pay telehealth and in-person visits, recently added prescription delivery through Truepill. It’s offering a list of generic medications for $5.
Pfizer has preliminary data showing its experimental drug for atopic dermatitis beat a blockbuster drug from Regeneron Pharmaceuticals in a head-to-head clinical trial. But the […]
The company makes software to spot diagnostic errors in radiology and route patients to centers of excellence.
College is a time of transition, but for those managing chronic medical conditions, it may also be the first time they will be wholly responsible […]
Though Gilead Sciences leads the group of companies developing immunotherapies that target the cancer protein CD47, Pfizer contends that molecules it is getting through the […]
Full FDA approval makes the Pfizer/BioNTech Covid-19 vaccine the first to reach that milestone. But the regulatory decision also flagged a potential risk of heart […]
Founders Alessandra Henderson and Jannine Versi set out to build a digital health platform for people who are going through menopause. The New York-based startup […]
Startup HiberCell has acquired Genuity Science, a marriage that brings together two companies that apply AI and machine learning to drug research. HiberCell says Genuity […]
UnitedHealthcare and United Behavioral Health agreed to the settlement to resolve allegations that they illegally denied coverage for mental health and substance use disorder treatments. […]
In 2019, the Rockville Centre school district in Long Island, New York, was shaken by a string of student deaths, including the suicides of a […]
Bristol Myers Squibb blockbuster drug Opdivo is being pulled from the market after failing to meet the main goal of a confirmatory study. The voluntary […]
Jasmine De Moya, 17, has dreamed for years of working in the medical field, and she yearned to spend time with older people, missing her […]
Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies that serve as conduits for drug manufacturers, health insurers and pharmacies. More […]
Whether the pharmaceutical giant jumped or was pushed, its New York deal is a significant sign of the way the wind is blowing Johnson & […]
Dr. Leora Horwitz treats fewer and fewer covid patients at NYU Langone Medical Center in New York City. Still, she thinks there are too many. […]
Rachel Blank, former director of strategy at digital health unicorn Ro, left to start her own digital health company. Her new startup, Allara is focused […]
The FDA has approved Prevnar 20, a Pfizer vaccine that protects against 20 pneumococcal strains—seven more than the company’s blockbuster Prevnar 13. But others are […]
The at-home testing startup plans to launch a broader virtual care offering after raising $150 million in funding. It plans to roll out virtual visits […]
Stablix Therapeutics is developing technology that uses small molecules to stabilize a protein, keeping it from going to a cell’s built-in disposal system. The startup […]
Emergency authorization of Regeneron Pharmaceuticals’ Covid-19 antibody drug now includes an injectable version, which is a more convenient option for patients. The drug developer plans […]
The startup, which currently has four direct-to-consumer brands, recently passed a $1 billion valuation. It plans to use the funds to market its services to […]
Noom, a weight loss app that uses health coaching, raised $540 million in a funding round led by Silver Lake Capital. It plans to expand […]
As the world of healthcare benefits becomes increasingly fragmented, Cedric Kovacs-Johnson sees a need for benefits administration to keep up. His startup, Flume, recently made […]
Bristol Myers Squibb reported Phase 3 data that show its experimental cancer immunotherapy relatlimab, combined with the company’s blockbuster drug Opdivo, was better at stopping […]
Healthcare payments startup Cedar acquired another billing startup, OODA Health, for $425 million. The deal would bring together billing tools for providers and payer onto […]
Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is looking […]
Headway, a startup working to build a network of therapists covered by major insurers, raised $70 million in funding. The startup manages claims, credentialing and […]
Founded by former hedge fund manager Vivek Ramawamy, Roivant Sciences set out to redefine drug development by acquiring overlooked drugs and advancing their development. The […]
As awareness grows around GI conditions, startup Oshi Health is building a platform to connect people to teams of clinicians and health coaches to better […]
Sesame, a startup building a cash-pay marketplace for healthcare, raised $24 million. The sudden adoption of telehealth by the broader public led the startup to […]
Kaia Health, a startup providing app-based programs for musculoskeletal conditions and COPD, recently raised $75 million in funding. As competitors look to round out their […]
The FDA placed a clinical hold on a KalVista Pharmaceuticals drug being readied for mid-stage studies in a rare, inherited disorder. Meanwhile, the FDA has […]
A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug […]
As Covid-19 cases started escalating last April, providers in hotspot states, like New York, California and Washington, had to quickly pivot their IT plans. These […]
Do mobile phones cause brain tumors? Whenever a trillion-dollar industry is involved—whether it’s Big Food, Big Tobacco, Big Pharma, or Big Telecom—there’s so much money […]
Volastra Therapeutics is developing drugs for cancer metastasis, the cause of the vast majority of cancer deaths. The startup has $44 million in funding and […]
The startup, which provides primary care services to Medicaid patients, plans to use the funds to expand into new states and add maternity and pediatrics […]
The FDA has approved a Bristol Myers Squibb cell therapy made by engineering a patient’s immune cells to target a cancer protein called BCMA. The […]
Komodo, a data analytics startup building out information on patient encounters and outcomes, raised $220 million in funding. It plans to use the funds to […]
Hawaii, Florida, Seattle and the South of France are on the minds of New York City college students. Those are some of the destinations that […]
Happify Health, a startup building digital health tools, raised $73 million in funding. The company plans to use the funds to build out more specialized […]
Unite Us, a New York-based technology company that makes coordination of care software, passed a $1.6 billion valuation. It build networks with local providers and […]
A Brainstorm Cell Therapeutics therapy for Lou Gehrig’s disease failed a pivotal study, but the company points to better results in a subgroup. The FDA […]
Takeda Pharmaceutical gains full rights to a small molecule that has shown promise treating seizures in several rare forms of epilepsy. Meanwhile, Ovid Therapeutics gains […]
The plaudits have faded for New York Gov. Andrew Cuomo. Once hailed as a paragon of pandemic governing, he’s since come under scorching criticism for […]
Athenex’s bid to offer an oral version of an intravenous chemotherapy has stalled after the FDA rejected the drug. Among the remedies proposed by the […]
After a year of record growth, Teladoc set expectations for limited growth in its paid memberships and visits in 2021. But the company still sees […]
Roivant Sciences is expanding its drug discovery and design capabilities via a stock deal to acquire Silicon Therapeutics. The Boston startup uses physics-based modeling to […]
This story also ran on The Guardian. It can be republished for free. In his 17 years as an emergency medical provider, Anthony Almojera thought […]
Insurance startup Oscar Health plans to price its IPO between $32 and $34 per share. The New York-based startup plans to trade on the New […]
Pfizer and BioNTech say they have data supporting two-week storage of their vaccine at temperatures found in medical-grade freezers. They say FDA approval of an […]
A physician started a business to eliminate long appointment wait times. But when the pandemic hit, she found a new use for it in helping […]
The FDA approval clears Regeneron’s drug, Evkeeza, as a treatment for the rarer of two forms of an inherited disease that causes high cholesterol levels. […]
Zocdoc, which had built its business as an online scheduling platform for doctors, quickly pivoted at the beginning of the pandemic to offer telehealth visits. […]
Oscar Health filed preliminary paperwork for an IPO on Friday. The health insurance startup is betting that its technology can give it an edge as […]
After some setbacks and delays, the FDA approved Bristol Myers Squibb’s Breyanzi for certain lymphomas. It’s the third CAR T treatment to win the regulatory […]
Digital health startup DarioHealth bought musculoskeletal startup Upright for $31 million. The company makes adhesive devices users can stick to their back to track their […]
Loki Therapeutics is advancing research that leverages the immune system’s ability to recall childhood vaccinations and direct it against cancer. The company’s lead therapy candidate […]
Cuando los hospitales de todo el país luchan contra la nueva ola de la pandemia, no son camas ni ventiladores lo que escasean. Son las […]
K Health raised $132 million in funding, which it plans to use to expand its platform into pediatric patients. The company has built a symptom-checker […]
Paige, a New York-based computational pathology startup, raised $100 million in a series C funding round. The company develops clinical decision support algorithms for oncology.
In an effort to ensure the efficient and orderly distribution of the Covid-19 vaccine, governors from New York, California and Florida are warning that they […]
Judges picked TrialSpark as the winner on the life sciences track of the pitch competition at MedCity’s virtual precision medicine conference. While the company is […]
This story also ran on The Guardian. It can be republished for free. Workers at Garfield Medical Center in suburban Los Angeles were on edge […]
No single municipality in the country suffered more in the first wave of the pandemic than New York City, which saw more than 24,000 deaths, […]
Spring Health, a startup that offers mental health services as an employee benefit, raised $75 million in funding. The New York-based startup matches employees with […]
Not long after the world learned that President Donald Trump had lost his reelection bid, states began issuing a new round of crackdowns and emergency […]
The New York based startup is working to build a network of therapists and other mental health providers. It recently raised a $26 million series […]
NEW YORK — Mike Angevine lives in constant pain. For a decade the 37-year-old has relied on opioids to manage his chronic pancreatitis, a disease […]
As COVID-19 cases surge in the U.S., one Texas veterinarian has been quietly tracking the spread of the disease — not in people, but in […]
As trust in the Food and Drug Administration wavers, several states have vowed to conduct independent reviews of any COVID-19 vaccine the federal agency authorizes. […]
The companies expect the deal to close in the fourth quarter. MyoKardia’s lead drug candidate is mavacamten, which it is developing for hypertrophic cardiomyopathy and […]
The data from a Phase II pilot and an extension study of soticlestat, also known as OV935 or TAK-935, showed short- and long-term reductions of […]
The company said that those who received the two-antibody cocktail REGN-COV2 showed a lower viral loads and faster alleviation of symptoms than those who received […]
Molina announced it will acquire the assets of Affinity Health Plan, a New York-based Medicaid managed care organization. It’s one of several Medicaid MCO purchases […]
Dr. Reza Chowdhury didn’t charge copays when his patients were low on cash. He gave them his home phone number and answered their medical questions […]
The healthcare analytics company said it had raised the extension funding from three new investors and would use it to accelerate development of its real-world […]
On the first night of the Democratic National Convention, New York Gov. Andrew Cuomo was among the first in a weeklong parade of speakers to […]
The companies also said their Phase II/III study, slated to enroll about 30,000 participants, had already dosed more than 11,000.
The deal brings Roche’s considerable manufacturing heft to Regeneron’s efforts to develop the two-antibody cocktail, REGN-COV2. Regeneron will distribute the drug in the U.S., while […]
Nearly all of the states, plus five territories and the District of Columbia, are seeking an aggregate of $2.156 trillion from the maker of the […]
Thirty Madison, which owns direct-to-consumer pharmacy brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led […]
The company plans to train 250 new racially and ethnically diverse clinical trial investigators and extend the reach of its trials to underserved rural and […]
Health workers across the country looked on in horror when New York became the global epicenter of the coronavirus. Now, as physicians in cities such […]
Vilified, threatened with violence or in some cases suffering from burnout, dozens of state and local public health officials around the U.S. have resigned or […]
Gilead Sciences had said in its second-quarter earnings that it would partner with companies in North America, Europe and Asia to manufacture the antiviral drug, […]
Insurance startup Oscar Health plans to expand to 19 new markets next year, pending regulatory approval. The company will offer individual and family health plans […]
The companies’ resubmission of their application Wednesday seeking approval for idecabtagene vicleucel was in line with the timeline they provided in May, when the FDA […]
The companies said they had started a Phase II/III trial BNT162b2. The news comes the day after Moderna announced the launch of its Phase III […]
NEW YORK — As the coronavirus spread silently through New York City early this year, Deborah Koeppel had an appointment with her cardiologist and two […]
In a panel discussion during MedCity INVEST Thursday, investors discussed how the Covid-19 pandemic and social distancing requirements have impacted the way they interact with […]
The companies will supply 100 million doses of the vaccine by the end of the year, and the government will have the option to acquire […]
Kaia Health, a startup making an app to help users manage back pain, touted the results of a large, randomized controlled trial using its app. […]
Israel Shippy doesn’t remember much about having COVID-19 — or the unusual auto-immune disease it triggered — other than being groggy and uncomfortable for a […]
Medly, a New York-based digital pharmacy startup that offers same-day prescription delivery, raised $100 million in a series B round.
In exchange for a $20 million upfront payment and up to $212.5 million in milestones, Italy-based Angelini will gain exclusive development, manufacturing and commercialzation rights […]
The companies anticipate releasing more clinical data from the BNT162 messenger RNA vaccine program and potentially starting a 30,000-participant Phase IIb/III study this month.
Bari Kowal, vice president of global clinical operations at Regeneron Pharmaceuticals, gives an update on the clinical trials ongoing to develop drugs to fight Covid-19 […]
The contract covers manufacture and supply of the two-antibody drug cocktail REGN-COV2. The company had announced Monday that it entered the drug into three late-stage […]
The company also said that the Phase III study of the autoimmune disease drug Kevzara that it was running with Sanofi failed to meet either […]
Copyright © 2024 | WordPress Theme by MH Themes